The AngioVac Device and Its Anesthetic Implications

ALTHOUGH THE EXACT incidence of venous thromboembolism (VTE) is not known, about 1 million cases are reported in the United States each year,1 and VTE is the third most frequent cardiovascular disease after myocardial infarction and stroke.2 The term VTE encompasses both deep venous thrombosis (DVT) and pulmonary embolism (PE).3 DVT may be found in any location, with the lower extremities being the most common site. Once formed, venous thrombi either remain in the peripheral veins, undergo endogenous fibrinolysis and recanalization, or embolize to the pulmonary arteries and cause PE.

Source: Journal of Cardiothoracic and Vascular Anesthesia - March 18, 2017 Category: Anesthesiology Authors: Harish Ram, Rebecca M. Gerlach, Antonio Hernandez Conte, Danny Ramzy, Ashley R. Jaramillo-Huff, Neal S. Gerstein Tags: Emerging Technology Review Source Type: research